In recent developments, the United States is reportedly in talks with India in bilateral and multilateral channels in order to discuss the supply of vaccines for the coronavirus.
Moreover, it seeks to inquire about its timeline for restarting vaccine exports, a senior Biden administration official said. According to reports, the global pandemic will be a key topic on Sept. 24, when U.S. President Joe Biden will host the first in-person summit of leaders of the "Quad" countries - Australia, India, Japan and the United States.
In addition, the visit by Prime Ministers Scott Morrison, Narendra Modi and Yoshihide Suga to the United States will coincide with the United Nations General Assembly in New York, which Biden will address on Sept. 21.
On the other hand, earlier on September 9, the health ministry released a four-month data of the national vaccination drive across India which stated that the effectiveness of the coronavirus vaccine in preventing mortality after the first dose stood at 96.6 per cent.
This reiterates the fact that vaccines offer near-total protection against serious disease and death. Moreover, the real-time data of COVID-19 vaccination between April 18 and August 15, showed the vaccine effectiveness in preventing deaths further enhanced after the second dose – and stood at an impressive 97.5 per cent.
ALSO READ: Panacea Biotec supplies 1st shipment of the second component of Sputnik V vaccine produced in India
Share
Tweet
